Table 1.
Effects of CPhGs on the liver and spleen indices of hepatic fibrosis rats
| Group | Dose (mg/kg/day) | n | Liver index (%) | Spleen index (%) |
|---|---|---|---|---|
| Normal | — | 12 | 2.21 ± 0.077** | 0.15 ± 0.010** |
| Model | — | 11 | 2.65 ± 0.245 | 0.19 ± 0.025 |
| BJRG | 600 | 10 | 2.21 ± 0.253** | 0.17 ± 0.013* |
| CPhGs | 500 | 12 | 2.32 ± 0.153** | 0.16 ± 0.025* |
| 250 | 9 | 2.40 ± 0.150** | 0.16 ± 0.017* | |
| 125 | 10 | 2.39 ± 0.103** | 0.16 ± 0.033 |
Values are expressed as mean ± SD, n = Survival number of animals
* P < 0.05, Compared with the model group;** P < 0.01, Compared with the model group